We are live on ! Find out more
2L

22NW LP Portfolio holdings

AUM $146M
1-Year Est. Return 29.83%
This Fund
S&P 500
This Quarter Est. Return
-2.86%
1 Year Est. Return
+29.83%
3 Year Est. Return
+131.37%
5 Year Est. Return
+199.25%
10 Year Est. Return
–
AUM
$146M
AUM Growth
-$91.7M
Cap. Flow
-$83.1M
Cap. Flow %
-56.95%
Top 10 Hldgs %
90.14%
Holding
21
New
1
Increased
3
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
NSP icon
Insperity
NSP
+$12.8M
2
FOXF icon
Fox Factory Holding Corp
FOXF
+$12.3M
3
MLYS icon
Mineralys Therapeutics
MLYS
+$2.52M
4
SRI icon
Stoneridge
SRI
+$1.88M

Top Sells

Rank Stock Value
1
ANEB
Anebulo Pharmaceuticals
ANEB
+$84.8M
2
MEC icon
Mayville Engineering Co
MEC
+$7.76M
3
MGTX icon
MeiraGTx Holdings
MGTX
+$4.66M
4
RGNX icon
Regenxbio
RGNX
+$4.53M
5
FSTR icon
Foster
FSTR
+$3.66M

Sector Composition

Rank Sector Weight
1 Healthcare 40.93%
2 Industrials 31.4%
3 Consumer Discretionary 21.39%
4 Materials 3.42%
5 Consumer Staples 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSTR icon
1
Foster
FSTR
$443M
$29.8M 20.41%
1,067,186
-123,860
-10% -$3.66M
NKTR icon
2
Nektar Therapeutics
NKTR
$2.39B
$20.2M 13.86%
281,115
-50,000
-15% -$2.85M
LFCR icon
3
Lifecore Biomedical
LFCR
$162M
$18.9M 12.93%
1,254
– –
NSP icon
4
Insperity
NSP
$1.85B
$13.3M 9.14%
493,000
+396,700
+412% +$12.8M
MLYS icon
5
Mineralys Therapeutics
MLYS
$2.35B
$12M 8.25%
444,325
+86,000
+24% +$2.52M
SRI icon
6
Stoneridge
SRI
$209M
$11.9M 8.17%
2,466,975
+274,211
+13% +$1.88M
FOXF icon
7
Fox Factory Holding Corp
FOXF
$776M
$11.2M 7.65%
+678,165
New +$12.3M
CULP icon
8
Culp Inc
CULP
$45M
$5.09M 3.49%
1,859,061
– –
CMT icon
9
Core Molding Technologies
CMT
$210M
$4.99M 3.42%
222,738
– –
RGNX icon
10
Regenxbio
RGNX
$623M
$4.13M 2.83%
492,759
-430,920
-47% -$4.53M
UFI icon
11
UNIFI
UFI
$117M
$3.04M 2.09%
852,455
– –
TISI icon
12
Team
TISI
$77.7M
$2.71M 1.86%
170,187
– –
RZLT icon
13
Rezolute
RZLT
$480M
$2.5M 1.72%
820,653
– –
FARM
14
DELISTED
Farmer Brothers
FARM
$2.48M 1.7%
1,955,526
– –
ELDN icon
15
Eledon Pharmaceuticals
ELDN
$276M
$1.96M 1.34%
636,364
– –
PFX icon
16
PhenixFIN
PFX
$83.9M
$1.68M 1.15%
43,115
-74,770
-63% -$3.2M
ANEB
17
DELISTED
Anebulo Pharmaceuticals
ANEB
– –
-15,467,300
Closed -$84.8M
MEC icon
18
Mayville Engineering Co
MEC
$772M
– –
-414,280
Closed -$7.76M
MGTX icon
19
MeiraGTx Holdings
MGTX
$1.09B
– –
-586,519
Closed -$4.66M
SSKN
20
DELISTED
Strata Skin Sciences
SSKN
– –
-536,995
Closed -$677K
PMD
21
DELISTED
Psychemedics Corporation
PMD
– –
-276,034
Closed -$442K

Similar funds

TA
TRB Advisors New York $146M AUM 3.71% 1-Year Est. Return
AFM
Aspetuck Financial Management Westport, Connecticut $146M AUM 33.29% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
AWM
Apex Wealth Management Bedford, New Hampshire $146M AUM 15.52% 1-Year Est. Return
AGP
Aspire Growth Partners Miromar Lakes, Florida $146M AUM 22.8% 1-Year Est. Return
SIM
Sentry Investment Management Stevens Point, Wisconsin $146M AUM 23.67% 1-Year Est. Return
AC
Anson Capital Tyrone, Georgia $146M AUM 18.69% 1-Year Est. Return
ECM
Endure Capital Management Austin, Texas $146M AUM

22NW LP's Q1 2026 Portfolio in Review

As of Q1 2026, 22NW LP held 21 positions worth $146M, down 39% from $238M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

22NW LP withdrew a net $83.1M in Q1 2026, closing 5 positions and reducing 4 holdings. Its most notable exit was Anebulo Pharmaceuticals, an estimated $84.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 66% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, 22NW LP opened a new position in Fox Factory Holding Corp worth $11.2M.

  • 22NW LP's largest Q1 2026 buy was Fox Factory Holding Corp: 678,165 shares worth $11.2M.
  • 22NW LP added most to Insperity in Q1 2026, an estimated $12.8M increase.
  • 22NW LP's biggest Q1 2026 reduction was Regenxbio, cutting an estimated $4.53M.
  • 22NW LP fully exited Anebulo Pharmaceuticals in Q1 2026, selling an estimated $84.8M.
  • 22NW LP's ten largest holdings make up 90% of its $146M portfolio in Q1 2026.
  • 22NW LP opened 1 new position and closed 5 in Q1 2026.
  • 22NW LP's portfolio value fell 39% quarter-over-quarter to $146M.

Based on 22NW LP's 13F filing for Q1 2026, filed 15 May 2026.